Welcome to LookChem.com Sign In|Join Free

CAS

  • or

4277-02-5

Post Buying Request

4277-02-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4277-02-5 Usage

General Description

1,2-Benzenedicarboxylic acid, 3,5-dinitro- is a chemical compound that is known for its use as a plasticizer in the production of polyvinyl chloride (PVC) as well as in the manufacturing of dyes, perfumes, and pharmaceuticals. It is a nitro derivative of phthalic acid and is categorized as a hazardous substance due to its toxic effects on the environment and human health. Exposure to 1,2-Benzenedicarboxylic acid, 3,5-dinitro- can cause irritation to the skin, eyes, and respiratory system, and long-term exposure may lead to potential reproductive and developmental toxicity. As a result, strict safety measures should be implemented in its handling, storage, and disposal.

Check Digit Verification of cas no

The CAS Registry Mumber 4277-02-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,2,7 and 7 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 4277-02:
(6*4)+(5*2)+(4*7)+(3*7)+(2*0)+(1*2)=85
85 % 10 = 5
So 4277-02-5 is a valid CAS Registry Number.

4277-02-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 3,5-dinitrophthalic acid

1.2 Other means of identification

Product number -
Other names 3,5-Dinitro-phthalsaeure

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:4277-02-5 SDS

4277-02-5Relevant articles and documents

S6K1 PROTEIN KINASE INHIBITORS AS CANCER THERAPEUTICS

-

Paragraph 0068; 0117, (2021/10/22)

The present disclosure relates to compounds that act as protein kinase inhibitors, especially RPS6K1 and the synthesis of the same. Further, the present disclosure teaches the utilization of such compounds in a treatment for proliferative diseases, including cancer, particularly breast cancer, and especially ER+ and/or HER2+ breast cancer, prostate cancer, lung cancer, and metastatic cancer.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 4277-02-5